| Drug Name |
Zaleplon |
| Drug ID |
BADD_D02379 |
| Description |
Zaleplon is a sedative/hypnotic, mainly used for insomnia. It is known as a nonbenzodiazepine hypnotic. Zaleplon interacts with the GABA receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zaleplon is a schedule IV drug in the United States. |
| Indications and Usage |
For the treatment of short-term treatment of insomnia in adults. |
| Marketing Status |
approved; illicit; investigational |
| ATC Code |
N05CF03 |
| DrugBank ID |
DB00962
|
| KEGG ID |
D00530
|
| MeSH ID |
C085665
|
| PubChem ID |
5719
|
| TTD Drug ID |
D09DWL
|
| NDC Product Code |
29300-131; 71335-1054; 71335-1387; 43063-783; 57237-239; 42043-210; 57237-240; 68788-7208; 53296-0056; 65862-215; 71335-0236; 0054-0085; 63629-3405; 65862-214; 16436-0056; 42043-211; 0054-0084; 71335-1466; 51846-1026; 65862-197; 29300-132; 43063-505; 43063-912; 45865-541; 64330-054 |
| UNII |
S62U433RMH
|
| Synonyms |
zaleplon | 3'-(3-cyanopyrazolo(1,5-alpha)pyrimidin-7-yl)-N-ethylacetanilide | N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide | L 846 | L-846 | Zelepion | Starnoc | SKP-1041 | CL 284,846 | CL-284846 | CL284,846 | CL 284846 | Sonata |
